Lyon F A, Frisch M J
Obstet Gynecol. 1976 Jun;47(6):639-43.
Recently the occurrence of adenocarcinoma of the endometrium has been reported in young women exposed to sequential oral contraceptive agents for long periods of time. Twelve young women who had been using Oracon for periods of from 13 to 93 months were subjected to office endometrial aspirations. Tissue specimens showed endometrium which varied in diagnosis from proliferative endometrium to severe atypical adenomatous endometrial hyperplasia bordering on endometrial carcinoma in situ. Adenomatous endometrial hyperplasia is though by many investigators to be a precancerous condition. The progression of endometrial changes from benign proliferation to cystic hyperplasia and adenomatous hyperplasia accompanied by varying degrees of anaplasia in young women exposed to Oracon for long periods of time is significant. It is not surprising, therefore, that adenocarcinoma of the endometrium has been reported in these women at an age where this condition had been relatively uncommon prior to the use of sequential oral contraceptives.
最近有报道称,长期服用序贯口服避孕药的年轻女性中出现了子宫内膜腺癌。12名服用Oracon长达13至93个月的年轻女性接受了门诊子宫内膜抽吸检查。组织标本显示,子宫内膜的诊断结果各异,从增殖期子宫内膜到严重的非典型腺瘤性子宫内膜增生,已接近原位子宫内膜癌。许多研究者认为腺瘤性子宫内膜增生是一种癌前病变。长期服用Oracon的年轻女性,其子宫内膜变化从良性增殖发展为囊性增生和腺瘤性增生,并伴有不同程度的间变,这一过程具有重要意义。因此,在这些女性中出现子宫内膜腺癌并不奇怪,因为在使用序贯口服避孕药之前,这种疾病在这个年龄段相对并不常见。